Optimization of a Crystallization Process for Orantinib Active Pharmaceutical Ingredient by Design of Experiment To Control Residual Solvent Amount and Particle Size Distribution
2015 ◽
Vol 19
(11)
◽
pp. 1655-1661
◽
2018 ◽
Vol 178
◽
pp. 1-10
◽
2019 ◽
Vol 23
(12)
◽
pp. 2666-2677
◽
1999 ◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
1998 ◽
Vol 84
(5)
◽
pp. 387-392
◽
Keyword(s):